Biodesix Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 10.21, this represents a new company high. This is a clear indication for improving liquidity at Biodesix Inc 's clients. Average receivable collection period, for the Biodesix Inc in Jun 30 2026 quarter, has decreased to 36 days, compared to 37 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 110 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 837 to 1220.

What is Receivable Turnover Ratio?
What is Biodesix Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BDSX Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	22.31 %	24.36 %	5.03 %	57.72 %	-26.43 %
Y / Y Revenue Change	34.18 %	42.3 %	40.76 %	19.93 %	11.68 %
Receivable Turnover Ratio (TTM)	10.21	9.94	9.62	8.82	9.65
BDSX's Total Ranking	# 1220	# 837	# 809	# 1206	# 1073
Accounts Receivable average collection period days	36	37	38	41	38
Seq. Receivable Change	-4.07 %	5.14 %	-28.7 %	70.1 %	-2.46 %
Seq. Revenue Change	5.11 %	-11.13 %	32.1 %	8.74 %	11.47 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 5
Healthcare Sector	# 111
Overall Market	# 1220

Receivable Turnover Ratio Statistics
High	Average	Low
10.21	8.17	6.25
(Jun 30 2026)		(Mar 31 2021)

BDSX Company Profile • Back to BDSX Efficiency Comparisons • Compare BDSX Receivables Turnover Ratio to its Competitors

Financial Statements
Biodesix Inc 's Accounts Receivable	$ 9 Millions	Visit BDSX's Balance sheet
Biodesix Inc 's Sales TTM	$ 103 Millions	Visit BDSX's Income Statement
Sources of BDSX's Revenues		Visit BDSX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BDSX's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BDSX's Growth Rates	BDSX's Roa	BDSX's Inventory Turnover Ratio	BDSX's Dividend Comparisons
BDSX's Profitability Ratios	BDSX's Roi	BDSX's Asset Turnover Ratio	BDSX's Dividend Growth
BDSX's Valuation Ratios	BDSX's Roe	BDSX's Financial Strength Ratios	BDSX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Ginkgo Bioworks Holdings Inc	30.60	$ 111.863 Millions	$ 3.656 Millions
Invo Fertility Inc	30.20	$ 7.531 Millions	$ 0.249 Millions
Kiniksa Pharmaceuticals International Plc	29.49	$ 840.848 Millions	$ 28.513 Millions
Wave Life Sciences Ltd	26.88	$ 81.746 Millions	$ 3.041 Millions
Igc Pharma Inc	26.21	$ 1.101 Millions	$ 0.042 Millions
Sonida Senior Living Inc	23.90	$ 525.973 Millions	$ 22.008 Millions
Marpai Inc	23.52	$ 16.635 Millions	$ 0.707 Millions
Agenus Inc	22.44	$ 132.693 Millions	$ 5.914 Millions
U S Physical Therapy Inc	22.40	$ 812.203 Millions	$ 36.251 Millions
Nutriband Inc	22.15	$ 1.618 Millions	$ 0.073 Millions
Iqvia Holdings Inc	20.31	$ 16,983.000 Millions	$ 836.250 Millions
Lineage Cell Therapeutics Inc	20.02	$ 13.083 Millions	$ 0.654 Millions
Hims and Hers Health Inc	19.65	$ 2,578.494 Millions	$ 131.228 Millions
Neuraxis Inc	18.95	$ 5.316 Millions	$ 0.281 Millions
China Pharma Holdings Inc	18.55	$ 3.914 Millions	$ 0.211 Millions
Bausch Health Companies Inc	18.42	$ 10,853.000 Millions	$ 589.250 Millions
Arvinas Inc	17.26	$ 316.700 Millions	$ 18.350 Millions
Nrx Pharmaceuticals Inc	17.25	$ 3.394 Millions	$ 0.197 Millions
Polomar Health Services, Inc.	17.19	$ 3.172 Millions	$ 0.185 Millions
Escalon Medical Corp	16.86	$ 12.736 Millions	$ 0.756 Millions
Anika Therapeutics Inc	16.70	$ 121.370 Millions	$ 7.266 Millions
Lifemd Inc	16.48	$ 163.363 Millions	$ 9.915 Millions
Longeveron Inc	16.43	$ 1.187 Millions	$ 0.072 Millions
Bioage Labs Inc	15.82	$ 10.355 Millions	$ 0.655 Millions
Vaxart Inc	15.09	$ 243.064 Millions	$ 16.108 Millions
Medicinova Inc	15.02	$ 0.920 Millions	$ 0.061 Millions
Voyager Therapeutics Inc	14.71	$ 34.459 Millions	$ 2.343 Millions
Halozyme Therapeutics Inc	14.68	$ 1,663.738 Millions	$ 113.332 Millions
Nexgel Inc	14.52	$ 11.810 Millions	$ 0.813 Millions
Skinhealth Systems Inc	14.42	$ 289.224 Millions	$ 20.051 Millions

Date modified: 2026-10-05T11:03:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.